期刊文献+

粪便隐血联合肿瘤标志物CEA、TPA、CYFRA211、CA125、CA199诊断结直肠癌的临床价值

Clinical Value of Fecal Occult Blood Combined with Tumor Markers CEA,TPA,CYFRA211,CA125,CA199 in Diagnosis of Colorectal Cancer
原文传递
导出
摘要 目的:探讨粪便隐血联合肿瘤标志物癌胚抗原(CEA)、组织多肽抗原(TPA)、细胞角蛋白19的可溶性片段(CYFRA211)、糖类抗原125(CA125)、糖类抗原199(CA199)诊断结直肠癌的临床价值。方法:选取2021年1月至2023年12月我院收治的87例结直肠癌患者作为研究组,选取同期于我院体检的87名健康志愿者作为对照组。比较2组受试者粪便隐血检查结果及血清CEA、TPA、CYFRA211、CA125、CA199水平;分析各指标单项与联合检测对结直肠癌的诊断效果。结果:研究组粪便隐血阳性率(74.71%)显著高于对照组(5.75%),P<0.05。研究组血清CEA、TPA、CYFRA211、CA125、CA199水平亦显著高于对照组,P<0.05。ROC曲线分析得出,粪便隐血、CEA、TPA、CYFRA211、CA125、CA199、联合诊断结直肠癌的AUC分别为0.845、0.745、0.755、0.876、0.779、0.758、0.972,敏感度分别为74.7%、50.6%、50.6%、77.0%、56.3%、100%、95.4%,特异度分别为94.3%、93.1%、100%、100%、100%、50.6%、96.6%。结论:结直肠癌患者粪便隐血阳性率高,且血清CEA、TPA、CYFRA211、CA125、CA199呈高表达,各指标联合检测可提高对结直肠癌的诊断效果。 Objective To investigate the clinical value of fecal occult blood(OB)combined with tumor markers carcinoembryonic antigen(CEA),tissue polypeptide antigen(TPA),soluble fragment of cytokeratin 19(CYFRA211),carbohydrate antigen 125(CA125)and carbohydrate antigen 199(CA199)in the diagnosis of colorectal cancer.Methods Total 87 patients with colorectal cancer admitted to our hospital from January 2021 to December 2023 were selected as study group,and 87 healthy volunteers who underwent physical examination in our hospital during the same period were selected as control group.The results of fecal OB test and serum levels of CEA,TPA,CYFRA211,CA125,CA199 were compared between the two groups to analyze the diagnostic effect of single and combined indexes on colorectal cancer.Results The positive rate of fecal OB in the study group(74.71%)was significantly higher than that in the control group(5.75%)(P<0.05).Serum levels of CEA,TPA,CYFRA211,CA125 and CA199 in the study group were significantly higher than those in the control group(P<0.05).ROC curve analysis showed that the AUC of fecal OB,CEA,TPA,CYFRA211,CA125,CA199 and combined diagnosis of colorectal cancer were 0.845,0.745,0.755,0.876,0.779,0.758 and 0.972,respectively.Sensitivity was 74.7%,50.6%,50.6%,77.0%,56.3%,100%,95.4%,and specificity was 94.3%,93.1%,100%,100%,100%,50.6%,96.6%,respectively.Conclusion The positive rate of fecal OB in patients with colorectal cancer is high,and the serum CEA,TPA,CYFRA211,CA125,CA199 are highly expressed.The combined detection of all indicators can improve the diagnostic effect of colorectal cancer.
作者 穆雪荣 林春芳 王志敏 MU Xue-rong;LIN Chun-fang;WANG Zhi-min(Department of Clinical Laboratory,Zhengzhou Third People's Hospital,Zhengzhou,Henan 45ooo0)
出处 《中国肛肠病杂志》 2024年第8期22-25,共4页 Chinese Journal of Coloproctology
关键词 结直肠癌 粪便隐血 癌胚抗原 组织多肽抗原 细胞角蛋白19的可溶性片段 糖类抗原125 糖类抗原199 诊断 Colorectal cancer Fecal occult blood Carcinoembryonic antigen Tissue polypeptide antigen Soluble fragment of cytokeratin 19 Carbohydrate antigen 125 Carbohydrate antigen 199 Diagnosis
  • 相关文献

参考文献8

二级参考文献93

  • 1陈海彬,周红光,李文婷,李沐涵,程海波,吴勉华.基于肠道菌群的结肠癌防治及与癌毒病机理论的关系[J].中华中医药杂志,2019,34(12):5796-5800. 被引量:18
  • 2武子涛,李世荣,韩英.粪便隐血试验在大肠癌筛检中的作用[J].华北国防医药,2004,16(5):305-307. 被引量:8
  • 3Moll R, Franke W W, Schiller D L. The catalogue of human cytokeratins:Pattems of expression in normal epithelia, tumours and cultured cells[J]. Cell, 1982,31:11.
  • 4Waseem A, Alexander C M, Steel J B, et al. Embryonic simple epithelial keratins 8 and 18:chromosomal location emphasises differenee from other Keratin reaction[J]. Genomies, 1990, 7:188.
  • 5Quinlan R A, Schiller D L, Hatzfeld M, et al. Patterns of Expression and organization of cytokeratin intermediate filaments[J]. Ann N Y Acad Sci, 1985,455:282.
  • 6Juang C M, Wang O H, Yen M S, et al. Application of tumor markers CEA,TPA, and SCC-Ag in patients with low, risk FIGO stage IB and ILA squamous cell carcinoma of the uterine cervix [J]. Gynecol Oncol,2000, 76(1):103.
  • 7Sanchez Carbayo M, Herrero E, Megias J, et al. Comparative sensitivity of urinary cyfra 21-1, urinary bladder cancer antigen, tissue polyeptide antigen and NMP22 to detect bladder cancer [J].Urol, 1999, 162(6):1951.
  • 8Bennink R, Van Poppel H, Billen J, et al. Serum tissue polypeptide antigen(TPA): Monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer[J]. Anticancer Res, 1999,19(4A):2609.
  • 9Thirapaga, P Wong C, Senapad S, et al. Accuracy of tissue polypeptide specific antigen(ITS)in the diagnosis of ovarian malignancy[J]. Antieaneer Res, 2000, 20(2B): 1291.
  • 10HOY J, Hsieh J F, Tasi S C, et al. Tissue poly peptide specific Antigen and squamous cell carcimoma antigen for early prediction of recurrence in lung squamous cell[J]. Carcimoma Lung, 2000, 178(2):75.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部